These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19191661)

  • 21. Guideline watch. Antiretroviral drug resistance testing--updated guidelines from the IAS-USA.
    Hicks CB
    AIDS Clin Care; 2008 Aug; 20(8):64. PubMed ID: 18814369
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.
    Bracciale L; Colafigli M; Zazzi M; Corsi P; Meraviglia P; Micheli V; Maserati R; Gianotti N; Penco G; Setti M; Di Giambenedetto S; Butini L; Vivarelli A; Trezzi M; De Luca A
    J Antimicrob Chemother; 2009 Sep; 64(3):607-15. PubMed ID: 19608581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluating the therapeutic care of HIV infection in Tunisia].
    Jlizi A; Slim A; Benammar Elgaaied A; Ben Rejab S; Ben Chaabane T; Letaief-Omezzine A; Chakroun M; Garbouj M
    Tunis Med; 2008 Jun; 86(6):534-9. PubMed ID: 19216443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug resistance guide being pondered by CDC. As HIV drug resistance rises, surveillance needed.
    AIDS Alert; 2003 Nov; 18(11):146-7. PubMed ID: 14674368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV drug resistance and you. Resistance overview. A look at the basics.
    Munk B
    Posit Aware; 2006; Spec No():6-9. PubMed ID: 16583502
    [No Abstract]   [Full Text] [Related]  

  • 26. Defining clinically relevant HIV drug resistance--from drug development to clinical reality.
    Miller V
    AIDS; 2006 Apr; 20(6):929-31. PubMed ID: 16549979
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparison of HIV-1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotype.
    Van Houtte M; Picchio G; Van Der Borght K; Pattery T; Lecocq P; Bacheler LT
    J Med Virol; 2009 Oct; 81(10):1702-9. PubMed ID: 19697398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transmitted HIV-1 drug resistance: are we seeing just the tip of an epidemiological iceberg?
    Stekler J; Coombs RW
    J Infect Dis; 2007 Aug; 196(3):336-8. PubMed ID: 17597446
    [No Abstract]   [Full Text] [Related]  

  • 29. New insights into HIV resistance testing: nursing guidelines and implications.
    Kirton CA; Kurtyka D; Sterken DJ
    J Assoc Nurses AIDS Care; 2007; 18(3):74-86. PubMed ID: 17570302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 drug resistance: where do polymorphisms fit in?
    Theys K; Abecasis AB; Vandamme AM
    Future Microbiol; 2013 Mar; 8(3):303-6. PubMed ID: 23464368
    [No Abstract]   [Full Text] [Related]  

  • 31. New developments in HIV drug resistance.
    Cane PA
    J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i37-40. PubMed ID: 19675018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality management of sequence-based methods for measuring HIV-1 drug resistance.
    Galli R; Wynhoven B; Harrigan R
    Am Clin Lab; 2002; 21(1):13-5. PubMed ID: 11975443
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy.
    Wang D; Larder B; Revell A; Montaner J; Harrigan R; De Wolf F; Lange J; Wegner S; Ruiz L; Pérez-Elías MJ; Emery S; Gatell J; D'Arminio Monforte A; Torti C; Zazzi M; Lane C
    Artif Intell Med; 2009 Sep; 47(1):63-74. PubMed ID: 19524413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug induced superinfection in HIV and the evolution of drug resistance.
    Leontiev VV; Maury WJ; Hadany L
    Infect Genet Evol; 2008 Jan; 8(1):40-50. PubMed ID: 18024234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of the K65R resistance reverse transcriptase mutation in different HIV-1 subtypes in Israel.
    Turner D; Shahar E; Katchman E; Kedem E; Matus N; Katzir M; Hassoun G; Pollack S; Kessner R; Wainberg MA; Avidor B
    J Med Virol; 2009 Sep; 81(9):1509-12. PubMed ID: 19626612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case files from Stanford University Medical Center: Drug resistance testing in previously untreated patients with HIV--knowing what to look for and choosing appropriate therapy.
    Shafer RW; Nguyen DP; Fessel WJ
    MedGenMed; 2006 Aug; 8(3):32. PubMed ID: 17406166
    [No Abstract]   [Full Text] [Related]  

  • 37. A sensitive replicative system to assess HIV-1 drug resistance.
    Klimkait T
    Am Clin Lab; 2002; 21(1):20-4. PubMed ID: 11975445
    [No Abstract]   [Full Text] [Related]  

  • 38. HIV treatment decisions and transmitted drug resistance.
    Little SJ; Smith DM
    Clin Infect Dis; 2005 Jul; 41(2):233-5. PubMed ID: 15983921
    [No Abstract]   [Full Text] [Related]  

  • 39. Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy.
    Di Giambenedetto S; Zazzi M; Corsi P; Gonnelli A; Di Pietro M; Giacometti A; Almi P; Trezzi M; Boeri E; Gianotti N; Menzo S; Del Gobbo R; Francisci D; Nerli A; Galli L; De Luca A;
    Antivir Ther; 2009; 14(3):359-69. PubMed ID: 19474470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
    Sungkanuparph S; Apiwattanakul N; Thitithanyanont A; Chantratita W; Sirinavin S
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):83-8. PubMed ID: 19323038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.